Placebo-controlled study on efficacy and safety of N-acetylysteine high dose in exacerbation of chronic obstructive plumonary disease.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned end date (31 Aug 2011) added as reported by Chinese Clinical Trial Register record.
- 20 Dec 2011 New trial record